Search clinical trials for: (Cystagon) Cysteamine Bitartrate

Total 867 results

Horizon Pharma USA, Inc.

Completed

Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in Cystinosis

Cystinosis

France, United States, United Kingdom, Belgium, Italy, Netherlands
Augusta University

Terminated

An Open Trial of Cysteamine Treatment in Schizophrenia

Schizophrenia | Schizoaffective

United States
University of California, San Diego
Raptor Pharmaceuticals Corp.

Completed

Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™

Cystinosis | Nephropathic Cystinosis

United States
Horizon Pharma USA, Inc.

Completed

Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis

Cystinosis

France, United States, Netherlands
National Institute of Diabetes and Digestive and...
National Cancer Institute (NCI); National Center for Advancing Translational... and other collaborators

Completed

Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children (CyNCh)

Nonalcoholic Fatty Liver Disease (NAFLD)

United States
University of Aberdeen
NHS Grampian; University of Huddersfield; Cystic Fibrosis Trust

Completed

First Study of Oral Cysteamine in Cystic Fibrosis

Cystic Fibrosis

United Kingdom
Chiesi SA/NV

Enrolling by invitation

Observational Study to Assess the Quality of Life in Nephropathic Cystinosis Patients (PROREAL)

Nephropathic Cystinosis

Belgium
Nacuity Pharmaceuticals, Inc.

Recruiting

PK and PD Study of NPI-001 and Cysteamine Bitartrate (INCA)

Cystinosis

Australia
Horizon Pharma USA, Inc.

Completed

Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis

Cystinosis

United States
Hospices Civils de Lyon

Completed

A Cohort of Patients With Cystinosis : Compliance to Cysteamine and Neurological Complications (Crystobs)

Cystinosis

France
Icahn School of Medicine at Mount Sinai

Terminated

Cysteamine Therapy for Major Depressive Disorder

Major Depressive Disorder

United States
Horizon Pharma USA, Inc.

Completed

Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease (MITO-001)

Inherited Mitochondrial Disease, Including Leigh Syndrome

United States
Horizon Pharma USA, Inc.

Terminated

A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease

Mitochondrial Diseases

United States
Children's Hospital Medical Center, Cincinnati

Completed

Cysteamine for Asthma

Asthma

United States
Eunice Kennedy Shriver National Institute of Child...

Completed

Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis

Infantile Neronal Ceroid Lipofuscinosis

United States
Horizon Pharma USA, Inc.

Completed

Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)

Cystinosis

France, United States, Netherlands
Assiut University

Not yet recruiting

Serum Cysteine Rich Protein 61 and Cystatin C for Early Detection of Acute Kidney Injury in Patients With Heart Diseases

Acute Kidney Injury
Assiut University

Unknown

Acute Kidney Injury in Newborns With Perinatal Asphyxia

Acute Kidney Injury
Sahlgrenska University Hospital, Sweden

Completed

Heart and Renal Failure in Hip Fracture Surgery

Renal Insufficiency | Hip Fractures | Hypotension | Heart Injuries

Sweden
Ain Shams University

Completed

Role of NGAL and Cystatin C in Prediction of Acute Kidney Injury Covid-19 Infection

Biochemical Markers ,NGAL,Cystatin c, Acute Kidneyinjury, Covid 19

Egypt
Chang Gung Memorial Hospital

Recruiting

Risk of Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy

Acute Kidney Injury

Taiwan
FDA Office of Orphan Products Development
Leadiant Biosciences, Inc.

Completed

Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis

Cystinosis
Assiut University

Unknown

Postoperative Acute Kidney Injury in Patients Undergoing Prolonged Neurosurgical Operations

Postoperative Acute Kidney Injury
Assiut University

Unknown

Cystatin c and Beta 2 Microglobulin in Thalassemic Children.

Blood Disease
Karolinska University Hospital

Active, not recruiting

Consistency Between Measures of Renal Function in ICU Patients

Critical Illness

Sweden
Chang Gung Memorial Hospital
Scientis Pharma SA

Recruiting

Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation

Hyperpigmentation; Postinflammatory

Taiwan
University Hospitals of Derby and Burton NHS Foundation...

Not yet recruiting

Multimorbidity and Sarcopenia Feasibility Study in Chronic Kidney Disease (MaSS-CKD)

Chronic Kidney Diseases | Sarcopenia
Horizon Pharma USA, Inc.

Completed

Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis

Cystinosis

United States, Brazil
Cairo University

Not yet recruiting

Salivary Cystatin S Levels in a Group of Egyptian Children

Early Childhood Caries
UnionDerm
Skin of Color Society; Solta Medical; Scientis

Recruiting

Combination Topical Cysteamine and Fractional 1927nm Low-Powered Diode Laser for Treatment of Facial Melasma

Melasma

United States
Cosmetique Active International

Recruiting

Efficacy and Tolerability of Test Product Versus Cysteamine 5% in Treatment of Facial Epidermal Melasma

Melasma

India
University Hospital, Basel, Switzerland

Completed

Estimation of Kidney Function Through Combination of Renal Biomarkers in Blood and Urine of Healthy Infants and Children. (KidMaCare)

Renal Biomarkers in Children

Switzerland
Tanta University
Ain Shams University

Completed

Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy

Diabetic Nephropathy

Egypt
Thiogenesis Therapeutics, Inc.

Not yet recruiting

Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19

COVID-19 | COVID-19 Acute Respiratory Distress Syndrome
Mayo Clinic

Completed

Cystatin-C C-guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project

Sepsis | Critical Illness | Methicillin-resistant Staphylococcus Aureus
University of Nebraska
National Cancer Institute (NCI)

Completed

Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer

Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer

United States
Joel Lavine
Raptor Pharmaceuticals Corp.

Completed

A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)

Fatty Liver

United States
Centre for Addiction and Mental Health

Completed

The Effect of Cysteine, Tryptophan and Tyrosine Supplements on Breast Milk

Healthy

Canada
China Medical University Hospital

Completed

Cysteamine Compared to Hydroquinone in Melasma

Melasma

Taiwan
Recordati Rare Diseases

Completed

Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2) (SCOB2)

Cystinosis

Belgium, France, United Kingdom, Germany, Italy
Amicus Therapeutics

Completed

A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients

Gaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher Disease

United Kingdom, United States
National Human Genome Research Institute (NHGRI)

Recruiting

Use of Cysteamine in the Treatment of Cystinosis

Cystinosis

United States
National Eye Institute (NEI)

Completed

New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis

Cystinosis

United States
University of Southern California
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Recurrent Prostate Cancer | Stage III Renal Cell Cancer | Recurrent Endometrial Carcinoma | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage IIIA Breast... and other conditions

United States
The Eye Center and The Eye Foundation for Research...

Completed

Efficacy of Topical Cysteamine in Nephropathic Cyctinosis

Nephropathic Cyctinosis | Corneal Cystine Crystals
National Eye Institute (NEI)

Completed

Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis

Cystinosis

United States
Amicus Therapeutics

Completed

A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy

Gaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher Disease

United States
Amicus Therapeutics

Completed

A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease

Gaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher Disease

United Kingdom, Israel, South Africa, United States
Ibtesam Hilmi

Completed

N-acetylcysteine in Liver Transplantation (NAC)

End Stage Liver Failure

United States
Columbia University

Completed

A Preliminary Study of Choline and Betaine Supplementation Among Adults Exposed to Arsenic in Bangladesh (CABS)

Arsenic Metabolites Measured in Urine

Bangladesh

Search clinical trials for: (Cystagon) Cysteamine Bitartrate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations